Reuters: Money News: Dr.Reddy's gains on key drug approval; brokers raise estimates

Reuters: Money News Reuters.com is your source for breaking news, business, financial and investing news, including personal finance and stocks. Reuters is the leading global provider of news, financial information and technology solutions to the world's media, financial institutions, businesses and individuals.

Want free Kindle ebooks? Sign up to receive the best freebie Kindle ebook deals in your email every day. From our sponsors

Dr.Reddy's gains on key drug approval; brokers raise estimates Sep 18th 2013, 05:22 Reuters Market Eye - Shares in Dr.Reddy's Laboratories up 1.2 percent after gaining 3.6 percent on Tuesday following the U.S. drug regulator's approval for selling a generic version of Celgene Corp's anti-cancer drug "Vidaza".

You are receiving this email because you subscribed to this feed at blogtrottr.com. If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions